News

Video

Managing Adverse Events in Patients Receiving Later Line Systemic Therapy for Metastatic TNBC

Author(s):

Nour Abuhadra, MD

Dr. Noor Abuhadra discusses managing adverse events in patients receiving TRODELVY (sacituzumab govitecan), a later-line systemic therapy for metastatic triple-negative breast cancer. Shay Elkins, a patient, shares her experience with significant side effects including diarrhea, low white blood cell counts, and hair loss, while Dr. Abuhadra emphasizes the need for proactive management of these issues to maximize treatment time and maintain quality of life.

Related Videos
Image of woman.
Image of Doctor.
Registered nurse Patricia Jakel emphasizes the importance of educating patients on evolving breast cancer research and the need for routine screenings.
Dr. Debu Tripathy highlights the importance of staying informed on breast cancer advancements and how this empowers patients to make informed decisions.
Image od grey haired Doctor.
Antibody-drug conjugates have had a tremendous impact on breast cancer care and treatment, according to Dr. Charles E. Geyer.
Image of man with grey hair.
Image of woman with blonde hair.
Related Content
Illustration of bonnie.
April 2nd 2025

Unexpected Challenges 11 Years After Breast Cancer

Bonnie Annis
Eleven years post diagnosis and issues related to breast cancer still frustrate me.
FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment
February 5th 2024

FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment

Alex Biese Brielle Benyon
One cancer vaccine may still be years away from being available, a breast cancer test may be misguiding treatments for Black women and the review of two oncology regimens are being expedited by the FDA.
Childhood cancer survivors are at risk of experiencing onset of aging-related disease 17.7 years sooner than the general population: © Konstantin Yuganov - stock.adobe.com
March 28th 2025

Childhood Cancer Survivors May Experience Sooner Aging-Related Disease

Alex Biese
Researchers have found childhood cancer survivors are at risk of experiencing onset of aging-related disease 17.7 years sooner than the general population.
Cancer Horizons podcast logo
December 12th 2023

Conference Highlights from SABCS

Alex Biese Brielle Benyon
CURE® recently covered the San Antonio Breast Cancer Symposium. In case you missed it, here is some news that came out of the conference that patients should know about.
Illustration of woman with grey hair.
March 26th 2025

Surviving Scans While Surviving Breast Cancer

Felicia Mitchell
Survivors facing new medical concerns may fear the unknown, but perseverance is possible as they navigate unexpected challenges in their new normal.
Dr. Regina Hampton illustrates how genomic insights have improved patient outcomes in breast cancer: © stock.adobe.com
March 23rd 2025

Unraveling Disparities and Genomic Advances Across Breast Cancer Care

Ryan Scott
Dr. Regina Hampton shares case studies from her own practice, illustrating how genomic insights have improved patient outcomes in those with breast cancer.